What Did the Trial Show on Gene Test Chemo?
6 Articles
6 Articles
Our science editor explains if you can talk about a medical breakthrough in the new genetic test.
Breast cancer has long been the leading cause of cancer incidence among women in Taiwan, and in recent years it has shown a trend of affecting younger women, causing many to fear the disease. However, with advancements in medical technology, chemotherapy is no longer the only option for all breast cancer patients. Dr. Chen Yi-Han, a breast surgeon at Ta-Chien General Hospital, points out that by assessing recurrence risk through genetic testing,…
What did the trial show on gene test chemo?
Genomic test to spare chemotherapy: what the OPTIMA trial found A large clinical trial—OPTIMA—evaluated whether a tumor genomic test could identify which breast cancer patients could safely avoid chemotherapy. The premise is straightforward: many patients receive chemotherapy even when their…
OPTIMA Trial: Some Breast Cancer Patients May Avoid Chemo
The exciting trial was discussed at ASCO’s annual meeting. Key Takeaways Some people with high-risk breast cancer may be able to safely forgo chemotherapy thanks to a genomic test developed based on BCRF work, according to a new study. The study, known as the OPTIMA trial, showed adding chemotherapy to endocrine therapy provided no added benefit to some patients with high clinical risk. The trial results shed important light on premenopausal w…
Genetic test may help breast cancer patients avoid chemotherapy
A major international study has found that a genetic test called Prosigna can help identify many women with early-stage breast cancer who may safely avoid chemotherapy, potentially sparing them from significant side effects without substantially affecting their chances of long-term survival.
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
